Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.
about
Epidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaEpidemiology of pancreatic cancerEnvironmental risk factors for pancreatic cancer: an update.High risk factors of pancreatic carcinoma.Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysisAssociations among Metabolism, Circadian Rhythm and Age-Associated DiseasesThe clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancerHereditary pancreatic cancer: related syndromes and clinical perspective.Risk factors for pancreatic cancer: a summary review of meta-analytical studies.Do variants associated with susceptibility to pancreatic cancer and type 2 diabetes reciprocally affect risk?Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links.Associations between metabolic disorders and risk of cancer in Danish men and women--a nationwide cohort study.Analysis of the Human Proteome in Subcutaneous and Visceral Fat Depots in Diabetic and Non-diabetic Patients with Morbid ObesityEffect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational StudyNew-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer.Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study.Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: A veteran administration registry study.Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.European cancer mortality predictions for the year 2017, with focus on lung cancer.The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017.Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma.Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults.Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study.Pancreatic cancer: Current status and Challenges.The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451.Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk.The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea.Pancreatic Cancer Risk is Modulated by Inflammatory Potential of Diet and ABO Genotype: A Consortia-based Evaluation and Replication StudyReply to the letter to the editor 'The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established' by Rahman and MeeranAssociation between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
P2860
Q26801418-CD32B02A-5712-4D15-B92D-64B70A4EA34FQ28079456-995F34A6-8635-42D7-BE6E-BE516E105796Q30248417-F467293C-9557-4B6D-8FBE-32540A3EA874Q30249161-E439624F-873C-4C8C-BDEC-E793C4880CC7Q33598407-F40D55F5-A5C9-4C08-A004-ADFD49EADA04Q33714257-890AB947-D877-4883-AF9C-67A48865D22DQ33798766-218D145D-7C77-4EB9-96CB-973E8036A3E0Q33851085-2372680E-142A-465A-89A4-81D5BA57D7BDQ34667061-9651CB8B-8DC7-4264-BD9A-B25A73104253Q35058384-BE0FC866-FA14-4689-AE6C-FA75F4FC7AC4Q35179959-43FCF425-560C-4BC6-BDE6-C698E3BE2E7BQ35930159-2241F48D-CB03-4ECD-ACD3-8726CA6E4127Q36156225-52AE1582-3583-44BD-B556-BB8ED31C8331Q36182971-FF782FBF-E1BC-49A8-A63C-F63E85951430Q36443863-E353E254-B704-4208-95BA-37CAD481F49CQ37061320-90C662F1-BFCE-49C1-A508-870ADB2B3A17Q37490985-B2CCF1AD-5CEC-46CD-B979-FF2EBBD7C8F5Q37705332-7BFA06C5-71E8-4812-98E6-3CF1CA097215Q37706025-C90D3260-B8D4-4552-9EEA-7D1D8E27BD2FQ38650099-7AA6533F-9A8D-4622-9A00-8382E494FF78Q38887446-C71F800C-8904-49D1-A438-58698CE45BDFQ39432270-E2A6AEE7-7D22-4F9C-86E4-23E45F599721Q39706900-151A6B90-2DBB-429A-81A0-CCEBC202402CQ39714372-71521C6D-ECE8-4EB5-8EC1-6BBCA7FE6C9FQ40255128-2D78055D-B974-4AFE-AF3A-FF383BBB2AA4Q40610844-B33F90F4-FDCC-4938-A502-355F43E6F361Q40721239-64205D71-CDF4-426D-A96C-EF6E981F3083Q50102282-26C3C738-F879-45AE-AC72-BC18D856B045Q50195669-A9F30A43-E8A0-48A7-A6D4-36379FBBDA56Q52699647-02032F07-9DAA-4F17-93B4-7872E9530907Q52726920-B355AE31-9600-4FA3-9799-1E53C1392FE5Q53210298-AA7E3E76-131D-477A-A78F-B7BB2F317D20Q55512214-BDEFD1C0-D2E5-423A-9C9E-1D2D95CF1C0BQ56089368-7115ADCA-7739-434D-9917-8DD06DF8A38EQ57558892-A1327949-9BF7-434A-BF5A-3C3E83C4840DQ58747747-BC0A4974-CD47-4ABF-8DD3-A5C92D380FA8
P2860
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@ast
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@en
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@nl
type
label
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@ast
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@en
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@nl
prefLabel
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@ast
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@en
Diabetes, antidiabetic medicat ...... ancer Case-Control Consortium.
@nl
P2093
P2860
P50
P356
P1433
P1476
Diabetes, antidiabetic medicat ...... Cancer Case-Control Consortium
@en
P2093
A B Miller
A Prizment
D Silverman
D Trichopoulos
E Fabianova
G M Petersen
P2860
P304
P356
10.1093/ANNONC/MDU276
P50
P577
2014-07-23T00:00:00Z